Differentiating nicotine- versus schizophrenia-associated decreases of the α7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes
- 11 December 2008
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 116 (2) , 213-220
Abstract
Nicotine addiction is prevalent in individuals with schizophrenia. Nicotine activation of nicotinic receptors (nAChRs) is time- and dose-dependent, but gene expression analyses often rely on qualitative self- or family-reported measures of smoking. We sought lymphocyte surrogates for cerebral α7-nAChR activity and tested if receptor transcription correlated with concurrently measured serum biomarkers for smoking [cotinine, C-reactive protein (CRP)]. PCR surveys to detect lymphocytic α7-related isoforms identified CHRFAM7A as the only consistently amplifiable transcript. In 20 smoking-matched people (n = 10 schizophrenia, n = 10 controls), we found significantly lower CHRFAM7A in cotinine and self-reported smokers versus nonsmokers (p ≤ 0.001–0.03) and an inverse correlation of cotinine with CHRFAM7A (p ≤ 0.04) in regression models. CHRFAM7A was not associated with diagnosis or CRP in any bi- or multi-variate analysis. Smoking-related CRP elevations only occurred in cotinine-based comparisons (p ≤ 0.03), and not when smoking was self-reported. Including biochemical indicators of serum nicotine can help differentiate smoking- versus disease-associated changes in nAChR expression.Keywords
This publication has 49 references indexed in Scilit:
- Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adultsBMC Public Health, 2007
- The Poor General Health of the Severely Mentally Ill: Impact of Schizophrenic DiagnosisCommunity Mental Health Journal, 2005
- Medical Morbidity and Mortality in SchizophreniaThe Journal of Clinical Psychiatry, 2005
- Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurementsEuropean Heart Journal, 2004
- Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjectsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
- Management of smoking in people with psychiatric disordersCurrent Opinion in Psychiatry, 2003
- Use of drugs, alcohol and tobacco by people with schizophrenia: case–control studyThe British Journal of Psychiatry, 2002
- Expression of an α7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytesJournal of Neuroimmunology, 2002
- Genomic Organization and Partial Duplication of the Human α7 Neuronal Nicotinic Acetylcholine Receptor Gene (CHRNA7)Genomics, 1998
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991